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Abstract
Caspases are a family of cysteine proteases that play key roles in programmed cell death (apoptosis). Mounting
evidence in recent years shows that caspases also have important non-apoptotic functions in multiple cellular
processes, such as synaptic plasticity, dendritic development, learning and memory. In this article, we review the
studies on the non-apoptotic functions of caspases in neurons, with a focus on their roles in synaptic plasticity,
learning and memory and neurodegeneration.
Introduction
Caspases are a family of cysteine proteases that have a
conserved cysteine residue at their active site and cleave
after an aspartate residue in their substrates. As key pro-
teolytic enzymes involved in programmed cell death (or
apoptosis), caspases are found in a wide range of animals
from worms to humans; in mammals, 12 caspases have
been identified. Caspases are generally translated as inac-
tive zymogens and activated through proteolytic cleavage.
Based on their structure and function, caspases are classi-
fied into two groups: initiator caspases and effector cas-
pases. Initiator caspases (caspase-1, -2, -4, -5, -8, -9, -10,
-11 and -12) have a long N-terminal prodomain through
which they are recruited to specific protein complexes
for activation. Once activated, initiator caspases can
cleave and activate downstream effector caspases (e.g.
caspase-3, -6, -7, -14), which then go on to proteolyze
further cellular substrates, of which many examples are
now known [1].
Since the discovery of the critical function of the
C. elegans caspase ced-3 in programmed cell death [2,3],
most members of the caspase family have been demon-
strated to be components of apoptotic signaling path-
ways. The biochemistry and function of these proteases
have been predominantly studied in the context of
apoptosis. In cells undergoing apoptosis, caspases are
activated by two main pathways: the extrinsic pathway
and the intrinsic pathway (see Figure 1). The extrinsic
pathway is initiated by binding of specific ligands (e.g.
tumor necrosis factor alpha [TNFa], Fas ligand, Nerve
growth factor [NGF]) to cell surface “death receptors”,
such as tumor necrosis factor receptor 1 (TNFR1), Fas
and nerve growth factor receptor p75NTR [4]. Upon
ligand binding, the death receptors multimerize and
recruit multiple adaptor molecules to form the death-
inducing signaling complex (DISC), which in turn inter-
acts with and activates the initiator caspases [1]. For
TNFR1, TNF receptor associated-protein with death
domain (TRADD), TNF receptor associated protein 2
(TRAF2), receptor associated protein kinase 1 (RIPK1),
cellular inhibitor of apoptosis proteins cIAP1 and
cIAP2, and Fas-Associated protein with Death Domain
(FADD) are recruited to form a DISC that activates cas-
pase-8 [5]. In the intrinsic (mitochondrial) pathway of
apoptosis (see Figure 1), death inducing stimuli activate
pro-apoptotic Bcl-2 family proteins to alter mitochon-
drial membrane permeability and induce cytochrome c
release from mitochondria [6]. Cytosolic cytochrome c
promotes the assembly of an apoptosome, a multimeric
protein complex containing Apaf-1 and cytochrome c
[7,8]. The apoptosome recruits and activates initiator
caspase-9, which then cleaves executioner caspase-3 or
-7 [9].
For a long period of time, caspases have been predomi-
nantly studied for their pro-apoptotic functions. How-
ever, functional studies of caspases in recent years have
changed this view. It is increasingly clear that caspases
have non-apoptotic functions in multiple cellular pro-
cesses, such as inflammation, cell differentiation and pro-
liferation [10]. In the nervous system, caspases have been
shown to play a non-apoptotic role in synaptic plasticity
[11,12], dendritic pruning during development in Droso-
phila neurons [13,14], chemotropic responses of retinal
growth cones in Xenopus [15], neurite outgrowth [16],
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and the development and maturation of olfactory sensory
neurons [17]. This review will focus on the functions of
caspases in modulating synaptic transmission under both
physiological and pathological conditions, and its rele-
vance to cognition.
Mitochondrial apoptotic pathway and caspase-3 in LTD
Synaptic plasticity, the ability of synapses to adjust their
strength, is an important means by which the nervous
system responds to prior experience and adapts to
environmental changes. The change in synaptic strength
can be transient (seconds to minutes) or last for pro-
longed period of time. Long-lasting forms of synaptic
plasticity play a crucial role in the refinement of neuro-
nal connections during development and in cognitive
functions such as learning and memory [18,19]. In the
mammalian brain, NMDA receptor-dependent long-
term potentiation (LTP) and long-term depression
(LTD) of synaptic transmission are two major forms of
long-lasting synaptic plasticity. The movement of
AMPA receptors into and out of the synapse appears to
be the primary cell biological mechanism underlying the
change of synaptic efficacy during LTP and LTD. How-
ever, the signaling pathways and molecular mechanisms
underlying LTP and LTD are not clearly understood.
One interesting feature of synaptic plasticity is the
morphological change that accompanies functional mod-
ification of the synapse. LTP is associated with forma-
tion and growth of dendritic spines [20-23] whereas
LTD is associated with shrinkage and loss of spines
[23-25]. We hypothesized that LTP and LTD reflect
opposing cell biological processes that control cellular
growth. Could the mediators of apoptosis - which repre-
sents the major pathway for controlled cellular involu-
tion - also play a role in the weakening and elimination
of synapses?
We recently reported that caspase-3 and the mitochon-




















Figure 1 Extrinsic and intrinsic pathways of apoptosis. The two major apopotosis pathways are illustrated. The extrinsic pathway is initiated
by ligand binding to death receptors on the plasma membrane. The intrinsic pathway is also called the mitochondrial pathway. Both pathways
lead to activation of caspases.
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induction [11]. In caspase-3 knockout mice, NMDA-
receptor dependent LTD in CA1 neurons is abolished,
whereas LTP can be induced normally. LTD is also speci-
fically blocked by pharmacologic inhibition of caspase-3
(the executioner caspase) and caspase-9 (the initiator cas-
pase upstream of caspase-3 in the intrinsic pathway of
apoptosis), but is unaffected by a caspase-1 inhibitor [11].
In LTD, caspase-9 and caspase-3 are activated through
the engagement of the intrinsic pathway by activation of
BAD, which is a pro-apoptotic Bcl-2 family protein [26]
(see Figure 2). BAD is also activated in apoptotic cells,
but in neurons undergoing LTD, BAD is activated to
a lower level and transiently, which leads to a moderate
degree of caspase activation that is sufficient to promote
AMPA receptor internalization [26]. More prolonged
and much higher levels of caspase-3 activation is requi-
red to induce cell death [26], and AMPA receptor
endocytosis may contribute to apoptotic signaling [27].
Active caspase-3 in neurons undergoing LTD is required
for AMPA receptor endocytosis without causing cell
death [11]. In caspase-3 knockout mice and BAD knock-
out mice that have deficient NMDA receptor-induced
caspase-3 activation, AMPA receptor internalization is
blocked [11,26]. Similarly, BAD and BAX KO mice are
defective for LTD [26]. LTD is also blocked by overex-
pression of Bcl-xl (an anti-apoptotic member of the Bcl2
family) or XIAP (a direct protein inhibitor of caspase-9
and caspase-3) [11] (see Figure 1). In contrast, LTP is
unaffected by pharmacologic, genetic or molecular dis-
ruption of caspase-3 and the intrinsic apoptotic pathway
[11,26,28]. Together these findings confirm the impor-
tance of the mitochondrial apoptotic pathway - which
culminates in activation of caspase-3 - specifically in the
induction LTD.
Figure 2 Involvement of mitochondria and intrinsic apoptotic pathway in LTD. The mitochondrial pathway is required for NMDA receptor-
dependent long-term depression of synaptic transmission. NMDA receptor activation leads to moderate activation of the mitochondrial pathway,
which is required for AMPA receptor endocytosis.
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The mitochondrial apoptotic pathway is engaged by
the protein phosphatase calcineurin and PP1, which are
activated downstream of NMDA receptors [19]. Active
calcineurin and PP1 dephosphorylate BAD to initiate
the mitochondrial apoptotic pathway in neurons [26,29].
The critical involvement of calcineurin/PP1 in the
intrinsic pathway of apoptosis can explain why these
protein phosphatases are necessary for LTD induction,
although this does not exclude the possibility that calci-
neurin/PP1 also act on other relevant substrates in LTD
(such as AMPA receptors, PSD-95) [19,30].
Active caspases are presumed to function in LTD as
proteolytic enzymes. Crucial steps in understanding the
mechanism of caspases are to identify the substrates of
caspase-3 that are relevant to LTD, and to figure out
how cleavage of these substrates leads to AMPA recep-
tor internalization. The pro-survival and pro-LTP pro-
tein kinase Akt (a known substrate of caspase-3 in cell
death) is thought to play a role in suppression of LTD
by phosphorylating and inhibiting GSK3b [31]. Overex-
pression of a mutant form of Akt that is not susceptible
to cleavage by caspase-3 prevents the induction of LTD,
consistent with the idea that Akt proteolysis by caspase-
3 is required for LTD in neurons [11]. Thus the mito-
chondria-caspase cascade can fit into the key signaling
pathways for LTD induction.
LTD is typically regarded as “homosynaptic” (occur-
ring only at stimulated synapses), though in some condi-
tions, it can also be observed at un-stimulated synapses
(“heterosynaptic LTD”) [32]. We postulate that only
mitochondria at or near the activated synapses take part
in LTD induction. Because LTD stimulation results in
only moderate and transient activation of the mitochon-
drial apoptotic pathway, activated caspases are restricted
to the vicinity of stimulated synapses, thereby preventing
long-distance spread of LTD. Although the spatial and
temporal properties of mitochondrial activation in LTD
are still unclear, we found that mitochondria can be
very close to synapses (some are even present in dendri-
tic spines), and their morphology, distribution and moti-
lity are regulated by synaptic stimulation [33].
Caspases in LTP and learning and memory
Caspase-1 (interleukin-1b-converting enzyme, ICE) is the
first identified mammalian member of the caspase family
[2]. Active caspase-1 proteolytically processes cytokines
IL-1b and IL-18, and is a well-known pro-inflammatory
caspase [1]. In addition to its pro-inflammatory function,
active caspase-1 has been shown to inhibit LTP. A peptide
caspase-1 inhibitor (z-YVAD-FMK) enhances NMDA
receptor-dependent LTP when applied to hippocampal
slices [12]. The effect of caspase-1 inhibitor on LTP could
be mediated by its substrate IL-1b, because application of
IL-1b to hippocampal slices inhibits LTP in CA1 [34],
CA3 [35] and dentate gyrus [36-38], and intracerebroven-
tricular injection of IL-1b into rats impairs LTP in dentate
gyrus [39,40]. However, there is no published evidence
from caspase-1 or IL-1b KO mice that this pathway is
involved in the control of synaptic plasticity.
Synaptic plasticity is crucial for cognitive functions of
the brain, such as learning and memory. Consistent with
their functions in LTD and LTP, caspase-3 and caspase-1
have been reported to contribute to learning and memory.
In the zebra finch auditory forebrain, caspase-3 activity is
necessary for memory consolidation during birdsong
learning, and novel-song exposure causes a rapid and tran-
sient release of active caspase-3 from its inhibitory protein
XIAP into dendritic spines [41]. Chronic brain infusion of
caspase-1 inhibitor in aged rats ameliorates age-related
increase in hippocampal IL-1b, and improves hippocam-
pus-dependent contextual memory [42]. The above phar-
macologic experiments suffer from the caveat of drug
specificity. Behavioral studies of caspase-3 and caspase-1
knockout mice have not been reported yet.
Caspases in neurodegeneration
Progressive decline in cognitive abilities is the prominent
symptom of Alzheimer’s disease (AD). Synapse loss and
reduction of synaptic proteins are detected in the hippo-
campus and cortex at early stages of AD, and correlate
with cognitive dysfunctions [43]. Synaptic pathology is
believed to be a major contributor to learning and mem-
ory impairment in AD, but its etiology remains unclear.
Active caspase-6, an effector caspase, has been reported
in post mortem brains of prodromal AD patients who do
not yet display apoptotic morphology, and the level of
caspase-6-cleaved Tau inversely correlates with the global
cognitive score [44]. The notion that caspase activity
might have detrimental non-apoptotic effects on synapses
in early AD is supported by recent studies in transgenic
mouse models of AD. In Tg2576 transgenic mice that
express mutant human amyloid precursor protein, cas-
pase-3 activity is enhanced in dendritic spines roughly
coincident with the onset of memory decline and in the
apparent absence of neuronal cell death in these animals
[45]. In Tg4510 Tau transgenic mice, which develop neu-
rofibrillary tangles, active effector caspases are detected
in some neurons preceding the appearance of tangles
[46]. Active effector caspases appear to initiate tangle for-
mation by cleaving tau, but do not induce cell death [46].
Analysis of synaptic functions in the Tg2576 mice sug-
gests that caspase activation leads to dephosphorylation
and removal of AMPA receptor subunit GluA1 from
synapses (possibly by activating calcineurin), altered glu-
tamatergic synaptic transmission, and enhanced LTD in
hippocampal CA1 neurons [45].
Impaired synaptic plasticity is also implicated in the
pathophysiology of AD. In vitro, amyloid b1-42 (Ab1-42)
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applied for two hours to hippocampal slices inhibits LTP;
this Ab-mediated inhibition depends on the mitochondrial
pathway of apoptosis, caspase-3, cleavage of AKT by cas-
pases, as well as GSK3b and BAX [28,47]. The impairment
of LTP by Ab requires NMDA receptor function, and con-
versely, Ab can enhance LTD [28,48]. However, unlike
LTD, caspase-9 inhibitor does not block the effect of Ab
on LTP [47], suggesting that Ab can activate caspase-3
through both mitochondria-dependent and mitochondria-
independent pathways. Thus Ab suppression of LTP
involves - at least in part – the same mechanisms as used
in LTD. These studies suggest that abnormally active cas-
pases may contribute to synaptic deficits in the AD brain,
even before frank neuronal death. It is intriguing that
injection of caspase-3 inhibitor into the Tg2576 transgenic
mice ameliorates the memory defects [45].
Conclusion
The discovery of caspases as amplifiers and executioners
of apoptosis highlighted their important role in pro-
grammed cell death. Until recently, the presence of active
caspases was believed to lead irreversibly to cell death,
and thus was a widely used marker of apoptotic cells.
However, active caspases can be also detected in cells
that are not destined to die, and it is now widely accepted
that caspases can play non-apoptotic roles in various
developmental and physiological contexts. In the past few
years, studies from several groups collectively point to an
essential function of caspases in synaptic plasticity, inde-
pendent of neuronal cell death. Two initiator caspases
(caspase-1 and caspase-9) and the effector caspase-3 are
shown to regulate long lasting synaptic plasticity in hip-
pocampal neurons. In particular, there is compelling evi-
dence that the induction of NMDA receptor-dependent
LTD is critically dependent on caspase-3 activation, and
moreover, active caspase-3 is sufficient to induce synaptic
depression. BAD and BAX induced mitochondrial release
of cytochrome c plays a crucial role in activating caspase-
3 in LTD. Active caspase-3 is required for AMPA recep-
tor endocytosis and consequent reduction of synaptic
strength, but the mechanism of how caspase-3 controls
AMPA receptor trafficking is still unclear.
Emerging evidence indicates that caspases are active in
early stages of AD, and could mediate synapse dysfunc-
tion and loss before the advent of cell death and neuro-
degeneration. These new insights have potential
implications for the treatment of AD, and they highlight
the regulatory role of caspases in synaptic plasticity
under both normal and pathological conditions.
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